| Dr William P Roman, DPM | |
|
1001 Sturdy Rd, Valparaiso, IN 46383-4126 | |
| (219) 462-7173 | |
| (219) 462-7504 |
| Full Name | Dr William P Roman |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 19 Years |
| Location | 1001 Sturdy Rd, Valparaiso, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760442271 | NPI | - | NPPES |
| 07001033A | Other | IN | LICENSE |
| 07001033B | Other | IN | CSR |
| P00399960 | Other | PALMETTO GBA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 07001033A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mary Medical Center Inc | Hobart, IN | Hospital |
| Franciscan Health Crown Point | Crown point, IN | Hospital |
| Northwest Health - Porter | Valparaiso, IN | Hospital |
| Provider Name | Healthlinc Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1528262581 PECOS PAC ID: 7618929373 Enrollment ID: O20050210000929 |
News Archive
Mirna Therapeutics, Inc., a leading developer of microRNA (miRNA)-based therapeutics, announced today that it will present new data at the inaugural CPRIT Innovations in Cancer Prevention and Research Conference, November 17-19, 2010 in Austin, TX.
In a recent study, researchers target the electropositive receptor-binding domain (RBD) on the SARS-CoV-2 spike protein with the abundant β-sheet structure as a novel COVID-19 therapeutic drug design.
Seeking to address estimates that more than a third of COVID-19 deaths nationally have occurred in nursing homes and long-term care facilities-more than 38,000 - the American Medical Directors Association published recommendations for reducing the spread of the pandemic virus among residents and staff.
In an assessment of their "depression literacy" program, which has already been taught to tens of thousands, Johns Hopkins researchers say the Adolescent Depression Awareness Program achieved its intended effect of encouraging many teenagers to speak up and seek adult help for themselves or a peer.
› Verified 4 days ago
| Provider Name | Roman Podiatry Partners Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1003472721 PECOS PAC ID: 7517292006 Enrollment ID: O20190703002014 |
News Archive
Mirna Therapeutics, Inc., a leading developer of microRNA (miRNA)-based therapeutics, announced today that it will present new data at the inaugural CPRIT Innovations in Cancer Prevention and Research Conference, November 17-19, 2010 in Austin, TX.
In a recent study, researchers target the electropositive receptor-binding domain (RBD) on the SARS-CoV-2 spike protein with the abundant β-sheet structure as a novel COVID-19 therapeutic drug design.
Seeking to address estimates that more than a third of COVID-19 deaths nationally have occurred in nursing homes and long-term care facilities-more than 38,000 - the American Medical Directors Association published recommendations for reducing the spread of the pandemic virus among residents and staff.
In an assessment of their "depression literacy" program, which has already been taught to tens of thousands, Johns Hopkins researchers say the Adolescent Depression Awareness Program achieved its intended effect of encouraging many teenagers to speak up and seek adult help for themselves or a peer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William P Roman, DPM 2308 N Roosevelt Rd, Valparaiso, IN 46383-2773 Ph: (219) 464-9588 | Dr William P Roman, DPM 1001 Sturdy Rd, Valparaiso, IN 46383-4126 Ph: (219) 462-7173 |
News Archive
Mirna Therapeutics, Inc., a leading developer of microRNA (miRNA)-based therapeutics, announced today that it will present new data at the inaugural CPRIT Innovations in Cancer Prevention and Research Conference, November 17-19, 2010 in Austin, TX.
In a recent study, researchers target the electropositive receptor-binding domain (RBD) on the SARS-CoV-2 spike protein with the abundant β-sheet structure as a novel COVID-19 therapeutic drug design.
Seeking to address estimates that more than a third of COVID-19 deaths nationally have occurred in nursing homes and long-term care facilities-more than 38,000 - the American Medical Directors Association published recommendations for reducing the spread of the pandemic virus among residents and staff.
In an assessment of their "depression literacy" program, which has already been taught to tens of thousands, Johns Hopkins researchers say the Adolescent Depression Awareness Program achieved its intended effect of encouraging many teenagers to speak up and seek adult help for themselves or a peer.
› Verified 4 days ago
Roman Podiatry Partners Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 2308 N. Roosevelt, Valparaiso, IN 46383 Phone: 219-464-9588 Fax: 219-462-4470 | |
South Shore Foot And Ankle Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 951 Transport Dr, Valparaiso, IN 46383 Phone: 219-464-4100 Fax: 219-464-4114 | |
Community Care Network, Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3800 Saint Mary Rd, Suite 204, Valparaiso, IN 46383 Phone: 219-286-3765 Fax: 219-286-3766 | |
Mobile Physicians Group Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2308 Roosevelt Rd, Valparaiso, IN 46383 Phone: 219-464-9588 Fax: 219-462-4470 | |
Timothy Alan Fitzgerald, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1101 Cumberland Xing # 262, Valparaiso, IN 46383 Phone: 219-299-4643 Fax: 219-267-1720 | |
Dr. Reem Mohammad, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2308 Roosevelt Rd, Valparaiso, IN 46383 Phone: 219-464-9588 | |
Emroc Podiatric, Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2 Spectacle Dr, Valparaiso, IN 46383 Phone: 219-840-0345 Fax: 219-728-4407 |